Trials / Completed
CompletedNCT03436992
Estrogen and Diabetes
Estrogen-Mediated Impairments of Vascular Health in Diabetes
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 143 (actual)
- Sponsor
- Augusta University · Academic / Other
- Sex
- All
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
Diabetes has recently been referred to as "the epidemic of the 21st century". The reason why women with type 1 diabetes have a 2-3 fold greater risk of cardiovascular disease (CVD) compared to men with type 1 diabetes is unknown.The purpose of this study is to investigate whether or not estrogen contributes to vascular dysfunction in premenopausal women with diabetes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Antioxidant Cocktail | Vitamin C, Vitamin E, alpha lipoic acid |
| DIETARY_SUPPLEMENT | Resveratrol | 1500 mg trans-resveratrol |
| OTHER | Placebo | placebo |
Timeline
- Start date
- 2018-04-17
- Primary completion
- 2023-09-01
- Completion
- 2023-12-31
- First posted
- 2018-02-19
- Last updated
- 2025-02-17
- Results posted
- 2025-02-17
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT03436992. Inclusion in this directory is not an endorsement.